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Abstract Glucose and fatty acid metabolism (oxidation versus
esterification) has been measured in hepatocytes isolated from
24 h starved peroxisome proliferator-activated receptor-K
(PPARK) null and wild-type mice. In PPARK null mice, the
development of hypoglycemia during starvation was due to a
reduced capacity for hepatic gluconeogenesis secondary to a 70%
lower rate of fatty acid oxidation. This was not due to
inappropriate expression of the hepatic CPT I gene, which was
similar in both genotypes, but to impaired mitochondrial
hydroxymethylglutaryl-CoA synthase gene expression in the
PPARK null mouse liver. We also demonstrate that hepatic
steatosis of fasting PPARK null mice was not due to enhanced
triglyceride synthesis. ß 2000 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The discovery of peroxisome proliferator-activated recep-
tors (PPAR), members of the superfamily of nuclear hormone
receptors, has provided new insights into the regulation of
gene expression by fatty acids and peroxisome proliferators
(reviewed in [1]). The PPAR family contains three distinct
isoforms: K, L/N and Q. Whereas the physiological impact of
the ubiquitous PPARL/N is still unknown (reviewed in [1]), it
has been shown that PPARQ is a major factor involved in
adipocyte di¡erentiation (reviewed in [2]). The phenotypic
characterization of PPARK null mice suggested that this re-
ceptor is mainly involved in the control of hepatic fatty acid
and glucose metabolism. For instance, a late onset sexually
dimorphic phenotype has been observed in PPARK null mice.
The 8-month-old females became obese whereas age-matched
males developed a centrilobular steatosis [3]. In younger ani-
mals, the most striking di¡erence in the phenotypes between
wild-type and PPARK null mice was observed during starva-
tion. During starvation, PPARK null mice developed severe
hypoglycemia [4,5] which was attributed to a defect in hepatic
glucose production [5]. As the expression of the gene encoding
phosphoenolpyruvate carboxykinase (PEPCK, the rate limit-
ing enzyme in gluconeogenesis) was normally increased in the
liver of fasting PPARK null mice [5], it was suggested that
hepatic gluconeogenesis was due to a limitation of fatty acid
oxidation. This conclusion was only based upon the fact that
the plasma L-hydroxybutyrate concentration was markedly
reduced in fasting PPARK null when compared to wild-type
mice [4,5]. Moreover, it was suggested that the development of
fatty liver during starvation in PPARK knockout mice re-
sulted from the impaired fatty acid oxidation. However, all
these assumptions were deduced from the level of mRNA
encoding speci¢c proteins without measurement of enzyme
activities or metabolic £uxes.
The aim of the present study was to determine (1) the rates
of gluconeogenesis and fatty acid oxidation in isolated hepa-
tocytes from fasting wild-type and PPARK null mice, (2) the
expression genes encoding regulatory proteins of these meta-
bolic pathways, and (3) the capacity for fatty acid esteri¢ca-
tion in hepatocytes isolated from fasting mice of both geno-
types.
2. Materials and methods
2.1. Animals
Three- to ¢ve-month-old wild-type or homozygous PPARK null
(3/3) mice on a C57BL/6 genetic background were used. They
were housed at 23‡C in individual plastic cages with light from
07.00 to 19.00 h. They had free access to water and food (in terms
of energy: 73% carbohydrate, 5% fat, 22% protein; A03, UAR, Epi-
nay, France). After intraperitoneal pentobarbital anesthesia (100 mg/
kg body weight), livers from fed and 24 h starved mice of both gen-
otypes were rapidly sampled, frozen in liquid nitrogen and kept at
380‡C until RNA extraction. Mice were starved for 24 h before
hepatocyte isolation.
2.2. Isolation and incubation of mouse hepatocytes
The livers from two wild-type and two PPARK null (3/3) mice
were perfused simultaneously with Hanks’ balanced salt solution
(HBSS, KCl 5.4 mM, KH2PO4 0.45 mM, NaCl 138 mM, NaHCO3
4.2 mM, Na2HPO4 0.34 mM, glucose 5.5 mM, HEPES 1 M, EGTA
50 mM, CaCl2 50 mM, pH 7.4). Livers were washed at a rate of 5 ml/
min using the portal vein. Then collagenase (0.025%) was added and
the perfusion rate was decreased to 4 ml/min. Hepatocytes (1^2U106
cells/ml) were incubated in 2 ml of oxygenated (O2 :CO2 95:5) glucose-
free HBSS for 1 h in a gyratory shaking water bath.
2.3. Glucose production rates and fatty acid metabolism
2.3.1. Glucose production. The rates of glucose production were
determined after 1 h incubation period in the absence (endogenous)
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or in the presence of lactate/pyruvate (10/1 mM). The incubations
were ended by adding 0.2 ml HClO4 (40% v/v).
2.3.2. Fatty acid oxidation and esteri¢cation. Long-chain and me-
dium-chain fatty acid metabolism was studied using [1-14C]oleate
(0.3 mM; 0.5 WCi/Wmol) plus carnitine (1 mM) and [1-14C]octanoate
(0.6 mM; 0.1 WCi/mmol), respectively. Both fatty acids were bound to
2% (w/v) defatted albumin. For studies of fatty acid oxidation and
ketogenesis, incubations were ended by adding 0.2 ml HClO4 (40%
v/v). The production of 14CO2 and labeled acid-soluble products was
determined as previously described for [14C]oleate [6] and
[14C]octanoate [7] respectively. For studies of oleate esteri¢cation, in-
cubations were ended by centrifugation for 30 s at 3000Ug. The lipids
from the chloroform/methanol (2:1 v/v) cell extracts were separated
by thin layer chromatography, as described previously [8].
2.4. Metabolite analysis
Glucose, L-hydroxybutyrate and acetoacetate concentrations were
measured in the neutralized perchloric ¢ltrates by enzymatic methods
as described previously [9].
2.5. Measurement of in vivo liver lipogenesis
Well fed and 24 h starved mice of both genotypes were injected
intraperitoneally with (250 WCi in 200 Wl) 3H2O (1 mCi/mmol). One
hour later, mice were anesthetized with sodium pentobarbital (800 mg/
kg body weight) and the livers were rapidly sampled. Saponi¢cation
and extraction of radiolabeled fatty acids were performed on 1 g of
liver according to Stansbie et al. [10].
2.6. Extraction and Northern blot analysis of total RNA
Total RNA from frozen tissues was extracted with guanidinium
thiocyanate followed by puri¢cation through a CsCl cushion gradient
according to Chirgwin et al. [11]. RNA was quanti¢ed by ultraviolet
absorbance at 260 nm (260/280 ratio s 1.8). Northern blot analysis of
total RNA (20 Wg) was performed after 1% agarose gel electrophoresis
in 2.2 M formaldehyde as previously described [12]. Hybridization of
the blots with an excess of [Q-32P]ATP-labelled synthetic oligonucleo-
tide speci¢c for the 18S rRNA subunit [13] allowed us to correct for
possible variations in the amount of RNA transferred onto the mem-
branes. The hybridization probes are the 2.6 kb PstI fragment from
PCK 10 [14], the 1.1 kb PstI fragment from glucose 6-phosphatase
(Glc-6-Pase) [15], the EcoRI fragment from p61a CPT I [16] and the
KpnI fragment from pMS1-hydroxymethylglutaryl (HMG)-CoA syn-
thase [17]. Probes were radiolabeled using the multiprime DNA label-
ing system (Amersham). Quanti¢cations were performed by scanning
densitometry of the autoradiographs.
2.7. Statistical analysis
Results are expressed as means þ S.E.M. Statistical analysis was
performed using the rank-order test [18].
3. Results and discussion
The blood glucose concentration in 24 h starved PPARK
null mice was 60% lower than in wild-type ones (2.8 þ 0.2
versus 7.4 þ 1.0 mM, n = 6, P6 0.01). These values were sim-
ilar to those reported for fasting PPARK +/+ and PPARK
3/3 bred on a SV129 background [4,5]. This suggests that
genetic background did not alter the glycemic response to
fasting. In PPARK null mice the fasting hypoglycemia could
be due, at least in part, to a reduced capacity for hepatic
gluconeogenesis. Indeed, the rate of glucose production meas-
ured from lactate/pyruvate was 20% lower in hepatocytes iso-
lated from PPARK null mice than in wild-type mice (Table 1).
This reduced capacity for gluconeogenesis in the liver of
PPARK null mice cannot be attributed to inappropriate in-
duction of the two rate limiting enzymes of gluconeogenesis,
PEPCK and Glc-6-Pase. As shown in Table 1 both PEPCK
and Glc-6-Pase gene expression were normally induced after
24 h starvation in the liver of PPARK null mice. Such results
were previously reported for PEPCK in SV129 background
mice [5]. Once PEPCK and Glc-6-Pase genes have been fully
induced, active hepatic gluconeogenesis is also dependent
upon cofactors (acetyl-CoA, ATP and NADH) provided by
mitochondrial fatty acid oxidation. Thus, we determined the
rates of long- and medium-chain fatty acid oxidation in hep-
atocytes isolated from each genotype. As shown in Table 2 the
rate of long-chain (oleate) fatty acid oxidation was 70% lower
in PPARK null mice than in wild-type ones. This did not
result from a limitation in the entry of long-chain fatty acids
into mitochondria since the expression of the CPT I gene (the
Fig. 1. A: Representative Northern blot analysis of mitochondrial CPT I and HMG-CoA synthase gene expression in the liver of fed and 24 h
starved PPARK null (3/3) and wild-type (+/+) mice. B: Densitometric quanti¢cation of mRNA levels. Results are means þ S.E.M. of four
wild-type mice and six PPARK null mice, the reference value (1) being the level of mRNA in the liver of fed wild-type mice. *P6 0.01 com-
pared to fed wild-type mice, 2P6 0.01 compared to 24 h starved wild-type mice.
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rate limiting enzyme in long-chain fatty acid oxidation, re-
viewed in [19]) was increased to the same extent in the liver
of 24 h starved wild-type and PPARK null mice (Fig. 1).
Long-chain fatty acid oxidation is controlled not only by tran-
scriptional activation of the CPT I gene but also through al-
losteric regulation by malonyl-CoA, a potent inhibitor of CPT
I activity (reviewed in [19]). However, it seems unlikely that
such a regulation could explain the reduced rate of long-chain
fatty acid oxidation in PPARK null mice, since the oxidation
of octanoate (which is independent of CPT I activity) was also
65% lower in hepatocytes from PPARK null mice than in
wild-type ones (Table 2). Whatever the fatty acid used, the
decrease in mitochondrial oxidation resulted from a reduction
in the synthesis of acid-soluble products (Krebs cycle interme-
diates+ketones) due to an 80% inhibition of ketone body pro-
duction (Table 2). This low rate of ketogenesis was due to an
impaired induction of the mitochondrial form of HMG-CoA
(mtHMG-CoA) synthase (the rate limiting enzyme of the ke-
togenic pathway [20]) in the liver of 24 h starved PPARK null
mice when compared to wild-type mice (Fig. 1). It is note-
worthy that mtHMG-CoA synthase gene expression was al-
ready decreased in the liver of fed PPARK null mice (Fig. 1).
Such a metabolic defect was previously described in hepatoma
cell lines [21] and in newborn pig liver [22] and was shown to
be responsible for an inhibition of mitochondrial fatty acid
oxidation. Indeed, an impaired utilization of acetyl-CoA in
the mtHMG-CoA synthase pathway induced the accumula-
tion of acetyl-CoA and/or L-oxidation intermediates that are
strong inhibitors of acyl-CoA dehydrogenases [23]. In addi-
tion, octanoate oxidation could be blunted in PPARK null
mice as the result of an impaired stimulation of medium-chain
acyl-CoA dehydrogenase (a PPARK target gene) gene expres-
sion during starvation [4]. Whether oleate oxidation could
also be limited in PPARK null mouse liver by inappropriate
expression of long-chain acyl-CoA dehydrogenase gene re-
mains to be determined.
Our data clearly show that mtHMG-CoA synthase gene
expression was impaired in PPARK null mouse liver despite
an increase in circulating free fatty acid concentration [5]. As
fatty acids induced mtHMG-CoA synthase gene expression
(reviewed in [20]), this suggested that transcriptional e¡ects
of fatty acids required PPARK as previously shown in vitro
[24]. Hepatic mtHMG-CoA synthase gene expression is also
controlled by cAMP and glucocorticoids during starvation
(reviewed in [20]). The absence of induction of liver
mtHMG-CoA synthase in fasting PPARK null mice could
be due to an insensitivity of the gene to cAMP or glucocorti-
coids for unknown reasons. By contrast, starvation-induced
CPT I, Glc-6-Pase and PEPCK gene expression seems to be
completely independent of PPARK. This was expected for the
PEPCK gene whose expression was not controlled by fatty
acid in the liver (Pe¤gorier and Girard, unpublished data),
but was more surprising for Glc-6-Pase and CPT I which
are both regulated by long-chain fatty acids [25,26]. Glc-6-
Pase and CPT I are also tightly regulated by changes in pan-
creatic hormones [25,26]. Thus, the induction of PEPCK, Glc-
6-Pase and CPT I genes during starvation could be mainly
due to the fall in plasma insulin and a rise in plasma glucagon.
Another possibility regarding the Glc-6-Pase and CPT I genes
is that their induction by long-chain fatty acids is a PPARK-
independent mechanism. Such a possibility has been recently
discussed [27].
The last aim of this work was to determine whether the
steatosis that develops during starvation in the liver of PPARK
null mice [4,5] could be due to any of the non-exclusive fol-
lowing mechanisms: (1) an increase in endogenous fatty acid
synthesis ; (2) an increase in fatty acid uptake by the liver, (3)
an increase in the capacity for hepatic triglyceride synthesis,
(4) a decrease in the processing and/or exportation of very low
density lipoprotein (VLDL).
Fatty acids used as precursors of triglycerides could theo-
retically come from endogenous fatty acid synthesis from glu-
Table 1
Rates of glucose production in mice of both genotypes
PPARK (+/+) PPARK (3/3)
Glucose production (nmol/h/106 hepatocytes) 540 þ 10 430 þ 20*
PEPCK mRNA (% of fed level) 260 þ 302 310 þ 302
Glc-6-Pase mRNA (% of fed level) 190 þ 202 160 þ 102
The rates of glucose production were measured from a mixture of lactate/pyruvate (10/1 mM) in 1 h incubated hepatocytes isolated from 24 h
starved mice of both genotypes. Endogenous glucose production (absence of gluconeogenic substrate) was subtracted from each value. Liver
PEPCK and Glc-6-Pase mRNA levels were measured in well fed and 24 h starved mice of both genotypes. Results are means þ S.E.M. of four
to six di¡erent mice. *P6 0.05 compared to wild-type mice (+/+); 2P6 0.01 compared to fed mice of the respective genotype.
Table 2
Long- and medium-chain fatty acid metabolism in hepatocytes isolated from 24 h starved PPARK (+/+) and PPARK (3/3) mice
[1-14C]Oleate converted (nmol/h/106 hepatocytes) [1-14C]Octanoate converted (nmol/h/106 hepatocytes)
PPARK +/+ PPARK 3/3 PPARK +/+ PPARK 3/3
CO2 2.9 þ 0.6 2.4 þ 0.4 22.6 þ 2.2 25.5 þ 1.7
ASP 25.0 þ 1.3 6.6 þ 0.6* 166 þ 29 43 þ 8*
Total oxidized 27.8 þ 1.7 9.0 þ 1.0* 188 þ 31 68 þ 6*
Triglycerides 20.6 þ 1.6 22.4 þ 1.4
Phospholipids 4.8 þ 0.5 3.0 þ 0.5
Total esteri¢ed 25.4 þ 2.0 25.5 þ 1.3
Acetoacetate 157 þ 28 24 þ 6* 271 þ 24 55 þ 6*
L-Hydroxybutyrate 175 þ 5 40 þ 3* 342 þ 36 90 þ 12*
Total ketones 331 þ 36 64 þ 8* 613 þ 50 145 þ 23*
Hepatocytes were incubated for 1 h in the presence of [1-14C]oleate (0.3 mM) plus carnitine (1 mM), or in the presence of [1-14C]octanoate
(0.6 mM). Both fatty acids were bound to 2% fat-free albumin. ASP means acid-soluble products, representing citric acid cycle intermediates
plus ketone bodies. Results are means þ S.E.M. of four di¡erent mice of each genotype. *P6 0.01 compared to wild-type mice (PPARK +/+).
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cose (lipogenesis) and/or from fatty acid uptake by the liver.
Hepatic lipogenesis is markedly reduced during starvation due
to the inhibition of the transcription of key regulatory enzyme
by long-chain fatty acids (reviewed in [28]). Therefore, if the
fatty acid-induced inhibition of lipogenic enzyme gene tran-
scription was dependent upon PPARK, then lipogenesis would
not be down-regulated during starvation in PPARK null
mouse liver. The rates of lipogenesis were indeed similar in
the livers of fasting wild-type and PPARK null mice (respec-
tively 2.6 þ 0.7 and 1.8 þ 0.5 Wmol/h/g wet weight, n = 3). This
suggest that the regulation of genes encoding key lipogenic
enzymes (fatty acid synthase, acetyl-CoA carboxylase) by
long-chain fatty acids is independent of PPARK as previously
suggested [29].
Once inside the hepatic cell, long-chain fatty acids may
undergo metabolism via two major pathways: (1) esteri¢ca-
tion to build up fatty acid esters (triglycerides, phospholipids)
and (2) oxidation to CO2 and ketone bodies. If we assume
that the sum of radiolabeled oleate recovered in di¡erent frac-
tions (CO2, ASP, esteri¢ed products) is a good index of oleate
uptake, then the capacity for oleate uptake is 35% lower in
PPARK null mouse hepatocytes (34 nmol/h/106 hepatocytes)
than in wild-type ones (53 nmol/h/106 hepatocytes). Although
the mechanism by which fatty acids are taken up by liver cells
is still a mater of debate (reviewed in [30]), a part of the
uptake could be mediated by a fatty acid transport protein
(FATP). As FATP is a PPARK target gene [31,32], the dis-
ruption of the PPARK gene could have reduced the amount of
FATP in hepatocytes of PPARK null mice and thus the oleate
uptake. Such a decreased capacity for fatty acid uptake by the
liver would explain the higher plasma free fatty acid concen-
tration in fasting PPARK null mice than in wild-type ones [5].
Although a greater proportion of fatty acid is converted into
triglycerides in hepatocytes from PPARK null mice (73%) than
in wild-type mouse hepatocytes (47%) as the consequence of
the lower fatty acid uptake, this does not explain why trigly-
cerides accumulate in PPARK null mice liver. Therefore, we
tested the possibility that hepatic steatosis could be due to an
enhanced capacity for esteri¢cation of fatty acids. Since octa-
noate cannot be incorporated directly into cell triglycerides
[7], the rate of oleate esteri¢cation was solely investigated.
As shown in Table 2 the rates of oleate esteri¢cation were
similar whatever the genotype studied. Altogether these results
clearly showed that hepatic steatosis in fasting PPARK null
mice was neither due to an increase in maximal capacity for
fatty acid esteri¢cation nor to an increase in fatty acid avail-
ability which was either similar (endogenous lipogenesis) or
decreased (fatty acid uptake) when compared to wild-type
mice.
As the expression of the genes encoding apolipoproteins E,
B [5] or CIII [33] was not a¡ected by PPARK knockout, this
suggests that the packaging of triglycerides into VLDL could
be normal and thus not responsible for the hepatic steatosis.
This does not exclude the possibility that triglyceride accumu-
lation in PPARK null mouse liver could be due to a defect in
the process of VLDL secretion.
In conclusion, our data clearly demonstrate that fatty acid
oxidation was markedly reduced in fasting PPARK null
mouse liver secondary to an impaired induction of mtHMG-
CoA synthase gene. This low rate of mitochondrial fatty acid
oxidation could have two major consequences on hepatic me-
tabolism: (1) a lower e⁄ciency of gluconeogenesis due to a
reduced availability in obligatory cofactors (acetyl-CoA, ATP
and NADH) and (2) a reduced uptake of long-chain fatty acid
by liver cells. This work also shows that the development of
hepatic steatosis in fasting PPARK null mice is not due to an
increased capacity for lipogenesis or fatty acid esteri¢cation.
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